Sato, Ayami; Fonseca, Ivone Izabel Mackowiak da 
; Nagamine, Márcia Kazumi ; Toledo, Gabriela Fernandes de; Olio, Rennan; Hernandez-Blazquez, Francisco Javier ; Yano, Tomohiro; Yeh, Elizabeth Shinmay; Dagli, Maria Lúcia Zaidan
Fonte: Frontiers in Veterinary Science. Unidade: FMVZ
Assuntos: MELANOMA ANIMAL, CÃES, NEOPLASIAS BUCAIS, NEOPLASIAS EM ANIMAL, CONEXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SATO, Ayami et al. Effects of alpha-connexin carboxyl-terminal peptide (aCT1) and Bowman-Birk protease inhibitor (BBI) on canine oral mucosal melanoma (OMM) cells. Frontiers in Veterinary Science, v. 8, p. 1-8, 2021Tradução . . Disponível em: https://doi.org/10.3389/fvets.2021.670451. Acesso em: 16 nov. 2025.APA
Sato, A., Fonseca, I. I. M. da, Nagamine, M. K., Toledo, G. F. de, Olio, R., Hernandez-Blazquez, F. J., et al. (2021). Effects of alpha-connexin carboxyl-terminal peptide (aCT1) and Bowman-Birk protease inhibitor (BBI) on canine oral mucosal melanoma (OMM) cells. Frontiers in Veterinary Science, 8, 1-8. doi:10.3389/fvets.2021.670451NLM
Sato A, Fonseca IIM da, Nagamine MK, Toledo GF de, Olio R, Hernandez-Blazquez FJ, Yano T, Yeh ES, Dagli MLZ. Effects of alpha-connexin carboxyl-terminal peptide (aCT1) and Bowman-Birk protease inhibitor (BBI) on canine oral mucosal melanoma (OMM) cells [Internet]. Frontiers in Veterinary Science. 2021 ; 8 1-8.[citado 2025 nov. 16 ] Available from: https://doi.org/10.3389/fvets.2021.670451Vancouver
Sato A, Fonseca IIM da, Nagamine MK, Toledo GF de, Olio R, Hernandez-Blazquez FJ, Yano T, Yeh ES, Dagli MLZ. Effects of alpha-connexin carboxyl-terminal peptide (aCT1) and Bowman-Birk protease inhibitor (BBI) on canine oral mucosal melanoma (OMM) cells [Internet]. Frontiers in Veterinary Science. 2021 ; 8 1-8.[citado 2025 nov. 16 ] Available from: https://doi.org/10.3389/fvets.2021.670451
